Tetralogic Pharmaceuticals Corp (OTCMKTS:TLOG) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.06 and traded as high as $0.08. Tetralogic Pharmaceuticals shares last traded at $0.05, with a volume of 7,501 shares changing hands.
The firm has a 50-day moving average price of $0.06 and a two-hundred day moving average price of $0.05.
About Tetralogic Pharmaceuticals (OTCMKTS:TLOG)
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells.
Featured Story: What is the definition of market timing?
Receive News & Ratings for Tetralogic Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tetralogic Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.